Lynn A. Tetrault
Independent Chair of the BoardMs. Lynn A. Tetrault, J.D., Esq., is Independent Director of Alumis Inc. from May 23, 2025. She has been Chair of the Board at NeoGenomics Laboratories, Inc. since, May 2022. She served as Independent Director at Acelyrin, Inc. since December 18, 2023 until May 2025. She served as Interim CEO at NeoGenomics Laboratories, Inc. until August 2022. She served a Non-Executive Chairman of NeoGenomics Laboratories, Inc. since October 2021 until March 28, 2022 and since March 28, 2022 served as its Executive Chairman until May 2022 and served as its Lead Independent since 2021 until October 2021 and serves as its Director since June 2015. She served as Executive Chairman and Principal Executive Officer at NeoGenomics, Inc. since March 28, 2022 until May 12, 2022. She serves as Independent Chair of the Board since October 07, 2021 and served as Interim Chief Executive Officer at NeoGenomics, Inc. since May 12, 2022 until August 15, 2022 and has been its Director since June 12, 2015. She served as Non-Executive Chairman of NeoGenomics, Inc. since October 07, 2021 until March 2022 and served as its Lead Independent Director since July 15, 2020 until October 07, 2021. She had been a Director at Rhythm Pharmaceuticals, Inc. since December 9, 2020 and served as its Independent Director and is its Lead Director. She served as an Executive Vice President of Human Resources and Corporate Affairs at AstraZeneca PLC since May 1, 2007 to March 2014. She worked from 1993 to 2014 with AstraZeneca. Ms. Tetrault worked at AstraZeneca PLC, serving in a variety of senior positions. Ms. Tetrault is the Founder and Principal of Anahata Leadership. She founded Anahata Leadership, Inc. in May 2017. Ms. Tetrault is a consultant. Prior to this, Ms. Tetrault served as Vice President of Corporate Affairs at AstraZeneca plc since July 1, 2006. She served as Vice President of Human Resources and Global Drug Development of AstraZeneca United Kingdom. Ms. Tetrault was responsible for all human resources strategy, talent management, executive compensation and related activities, internal and external communications, government affairs, corporate reputation and corporate social responsibility for AstraZeneca. Previously, she was Vice President of Human Resources for AstraZeneca U.S, a subsidiary of AstraZeneca PLC from the time of the merger in April 1999 to May 2004. Before the merger, she was Vice President of Human Resources for AstraZeneca Pharmaceuticals LP which was created in June 1998. She joined Astra USA in 1993 as Associate General Counsel in its legal department and served as Vice President - Human Resources from May 1996, to June 1998. Prior to the employment at Astra USA, she was in private law practice, from 1988 to 1992 and specialized in general corporate and health care law. She is a Director of Womens' Way. She is also a Fellow and Member of the Advisory Board of Simmons University Institute for Inclusive Leadership. Ms.Tetrault began her career as a lawyer in private healthcare practice in Boston. She serves as Director of Paradigm for Parity. She serves as Member of the Advisory Board of the Connors Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital in Boston, MA. She received her B.A from Princeton University in 1984 and J.D. from the University of Virginia Law School in June 1988.
Positions
- Company NameNeoGenomics, Inc.Stock CodeNEOPositionIndependent Chair of the BoardColleagues
- APAnthony P. ZookCEO & Director
- LALynn A. TetraultIndependent Chair of the Board
- WSWarren StonePresident & COO
- EAElizabeth A. FloegelChief Digital & Information Officer
- GPGary PassmanChief People & Culture Officer
- AJAbhishek JainExecutive VP & CFO
- ALAlison L. HannahMember of Scientific Advisory Board
- SMStephen M. KanovskyIndependent Director
- MAMichael A. KellyIndependent Director
- Company NameRhythm Pharmaceuticals, Inc.Stock CodeRYTMPositionIndependent Lead DirectorColleagues
- DPDavid P. MeekerChairman, President & CEO
- HCHunter C. SmithCFO & Treasurer
- AGAlastair GarfieldChief Scientific Officer
- YMYann MazabraudExecutive VP & Head of International
- JLJennifer LeeExecutive VP & Head of North America
- DWDavid W. J. McGirrIndependent Director
- LMLee M. KaplanChairman of Scientific Advisory Board
- SAStuart A. ArbuckleIndependent Director
